Peter Braun is Head of Global Access Strategy and Health Policy at Roche in Switzerland. In this role, Braun is responsible for leading global health policy, product communications and access strategy across the organization. Braun’s career at Roche began in 1991 and has spanned a variety of global, regional and affiliate roles across developed as well as emerging countries (US, Mexico, Belgium, The Netherlands, and Peru). In particular, as Lifecycle Leader of Herceptin and Tarceva, he led teams through multiple clinical study readouts as well as two global regulatory approvals. Prior to his current role, he worked as Roche’s General Manager of Peru. Braun holds an MBA from INSEAD and undergraduate degrees from the University of Pennsylvania and the Wharton School of Business.